# EDGAR Filing Document

**Accession Number:** 0000200217
**File Stem:** 0001193125-23-038664
**Filing Date:** 2023-2
**Character Count:** 9937
**Document Hash:** 131d17168b5f454b7f76ac6aec66cd6f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-038664.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001193125-23-038664

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sanofi
- **CENTRAL INDEX KEY:** 0001121404
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 133529324
- **STATE OF INCORPORATION:** I0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-60069
- **FILM NUMBER:** 23627096

**BUSINESS ADDRESS:**
- **STREET 1:** 46 AVENUE DE LA GRANDE ARMEE
- **CITY:** PARIS
- **STATE:** I0
- **ZIP:** 75017
- **BUSINESS PHONE:** 33153774400

**MAIL ADDRESS:**
- **STREET 1:** 46 AVENUE DE LA GRANDE ARMEE
- **CITY:** PARIS
- **STATE:** I0
- **ZIP:** 75017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SANOFI-AVENTIS
- **DATE OF NAME CHANGE:** 20040826

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SANOFI SYNTHELABO SA
- **DATE OF NAME CHANGE:** 20010104
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DODGE & COX
- **CENTRAL INDEX KEY:** 0000200217
- **STANDARD INDUSTRIAL CLASSIFICATION:** UNKNOWN SIC - 0000 [0000]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 555 CALIFORNIA STREET
- **STREET 2:** 40TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104
- **BUSINESS PHONE:** 4159811710

**MAIL ADDRESS:**
- **STREET 1:** 555 CALIFORNIA STREET
- **STREET 2:** 40TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**SCHEDULE 13G** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934** 

**(AMENDMENT NO. 1)\*** 

------

## Sanofi
**(Name of Issuer)** 

**Ordinary Shares and American Depositary Shares** 

**(Title of Class of Securities)** 

**80105N105** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

CUSIP NO. 80105N105 13G PAGE 2 OF 4 PAGES

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | NAME OF REPORTING PERSON<br> S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON<br>Dodge & Cox 94-1441976 | NAME OF REPORTING PERSON<br> S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON<br>Dodge & Cox 94-1441976 | NAME OF REPORTING PERSON<br> S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON<br>Dodge & Cox 94-1441976 |
| &nbsp;&nbsp;&nbsp; 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP\*<br> (a) ☐ (b) ☐<br>N/A | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP\*<br> (a) ☐ (b) ☐<br>N/A | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP\*<br> (a) ☐ (b) ☐<br>N/A |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | CITIZENSHIP OR PLACE OF ORGANIZATION<br>California - U.S.A. | CITIZENSHIP OR PLACE OF ORGANIZATION<br>California - U.S.A. | CITIZENSHIP OR PLACE OF ORGANIZATION<br>California - U.S.A. |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp;&nbsp;5 | SOLE VOTING POWER<br>24,281,804 Ordinary Shares and 80,182,293 American Depositary Shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp;&nbsp;6 | SHARED VOTING POWER<br>0 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp;&nbsp;7 | SOLE DISPOSITIVE POWER<br>24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | &nbsp;&nbsp;&nbsp;&nbsp;8 | SHARED DISPOSITIVE POWER<br>0 |
| &nbsp;&nbsp;&nbsp;9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares |
| &nbsp;&nbsp;&nbsp;10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES\*<br>N/A | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES\*<br>N/A | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES\*<br>N/A |
| &nbsp;&nbsp;&nbsp;11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>5.3% | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>5.3% | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>5.3% |
| &nbsp;&nbsp;&nbsp;12 | TYPE OF REPORTING PERSON\*<br>IA | TYPE OF REPORTING PERSON\*<br>IA | TYPE OF REPORTING PERSON\*<br>IA |

---

------

Item 1(a) <u>Name of Issuer</u>:

Sanofi

Item 1(b) <u>Address of Issuer's Principal Executive Offices</u>:

54, rue La Boétie

75008 PARIS

France

Item 2(a) <u>Name of Person Filing</u>:

Dodge & Cox

Item 2(b) <u>Address of the Principal Office or, if none, Residence</u>:

555 California Street, 40th Floor

San Francisco, CA 94104

Item 2(c) <u>Citizenship</u>:

California - U.S.A.

Item 2(d) <u>Title of Class of Securities</u>:

Ordinary Shares and American Depositary Shares

Item 2(e) <u>CUSIP Number</u>:

80105N105

Item 3 <u>If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) ☒ Investment Advisor registered under section 203 of the Investment Advisors Act of 1940

Item 4 <u>Ownership</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Amount Beneficially Owned</u>:

24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Percent of Class</u>:

5.3%

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Number of shares as to which such person has</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole power to vote or direct the vote:

24,281,804 Ordinary Shares and 80,182,293 American Depositary Shares

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared power to vote or direct the vote:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of:

24,996,804 Ordinary Shares and 84,189,074 American Depositary Shares

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared power to dispose or to direct the disposition of:

---

| | |
|:---|:---|
| Item 5 | <u>Ownership of Five Percent or Less of a Class</u>:  |

---

Not applicable.

---

| | |
|:---|:---|
| Item 6 | <u>Ownership of More than Five Percent on Behalf of Another Person</u>:  |

---

The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, Sanofi.

Item 7 <u>Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company</u>:

Not applicable.

Item 8 <u>Identification and Classification of Members of the Group</u>:

Not applicable.

Item 9 <u>Notice of Dissolution of a Group</u>:

Not applicable.

Item 10 <u>Certification</u>:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2023

---

| | |
|:---|:---|
| DODGE & COX | DODGE & COX |
| By: | /S/ Katherine M. Primas |
| Name: | Katherine M. Primas |
| Title: | Chief Compliance Officer |

---